Equities research analysts forecast that Eastman Chemical (NYSE:EMN) will report sales of $2.35 billion for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Eastman Chemical’s earnings, with the lowest sales estimate coming in at $2.31 billion and the highest estimate coming in at $2.46 billion. Eastman Chemical posted sales of $2.24 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.9%. The business is expected to report its next earnings report on Thursday, April 29th.

On average, analysts expect that Eastman Chemical will report full year sales of $9.17 billion for the current year, with estimates ranging from $8.86 billion to $9.45 billion. For the next financial year, analysts expect that the company will report sales of $9.53 billion, with estimates ranging from $9.22 billion to $9.82 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow Eastman Chemical.

Eastman Chemical (NYSE:EMN) last issued its earnings results on Thursday, January 28th. The basic materials company reported $1.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.50 by $0.19. The business had revenue of $2.19 billion for the quarter, compared to analyst estimates of $2.16 billion. Eastman Chemical had a net margin of 5.56% and a return on equity of 13.12%. The company’s revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.42 EPS.

EMN has been the subject of a number of research analyst reports. KeyCorp increased their target price on shares of Eastman Chemical from $96.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, January 15th. Wells Fargo & Company raised their price target on shares of Eastman Chemical from $114.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 2nd. Bank of America raised their price objective on shares of Eastman Chemical from $89.00 to $101.00 and gave the stock a “neutral” rating in a report on Monday, November 30th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Eastman Chemical from $95.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, December 2nd. Finally, Zacks Investment Research downgraded shares of Eastman Chemical from a “buy” rating to a “hold” rating and set a $105.00 target price for the company. in a research note on Thursday, January 28th. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $85.83.

In other Eastman Chemical news, EVP Brad A. Lich sold 26,042 shares of the company’s stock in a transaction that occurred on Monday, February 8th. The stock was sold at an average price of $104.94, for a total value of $2,732,847.48. Also, SVP Perry Stuckey sold 20,985 shares of the business’s stock in a transaction that occurred on Friday, February 12th. The shares were sold at an average price of $107.00, for a total value of $2,245,395.00. The disclosure for this sale can be found here. Insiders own 1.66% of the company’s stock.

Institutional investors have recently made changes to their positions in the stock. Fulcrum Equity Management purchased a new stake in Eastman Chemical in the fourth quarter worth $373,000. Achmea Investment Management B.V. boosted its position in shares of Eastman Chemical by 36.6% during the fourth quarter. Achmea Investment Management B.V. now owns 24,522 shares of the basic materials company’s stock valued at $2,459,000 after buying an additional 6,573 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Eastman Chemical by 5.1% in the fourth quarter. JPMorgan Chase & Co. now owns 12,917,694 shares of the basic materials company’s stock valued at $1,295,387,000 after acquiring an additional 630,045 shares during the period. National Pension Service lifted its holdings in Eastman Chemical by 1,127.4% in the fourth quarter. National Pension Service now owns 247,979 shares of the basic materials company’s stock valued at $24,867,000 after acquiring an additional 227,775 shares during the period. Finally, Symmetry Partners LLC lifted its holdings in Eastman Chemical by 12.2% in the fourth quarter. Symmetry Partners LLC now owns 9,578 shares of the basic materials company’s stock valued at $960,000 after acquiring an additional 1,043 shares during the period. Institutional investors own 84.43% of the company’s stock.

Shares of Eastman Chemical stock traded down $1.05 on Tuesday, hitting $112.36. The company had a trading volume of 658,760 shares, compared to its average volume of 898,265. The company has a market cap of $15.22 billion, a PE ratio of 32.78, a PEG ratio of 3.97 and a beta of 1.53. Eastman Chemical has a 52 week low of $34.44 and a 52 week high of $113.99. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.98 and a quick ratio of 1.23. The business has a 50-day simple moving average of $105.49 and a 200-day simple moving average of $91.66.

The firm also recently announced a quarterly dividend, which will be paid on Monday, April 5th. Stockholders of record on Monday, March 15th will be paid a dividend of $0.69 per share. This represents a $2.76 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date is Friday, March 12th. Eastman Chemical’s payout ratio is 38.71%.

About Eastman Chemical

Eastman Chemical Company operates as an advanced materials and specialty additives company worldwide. The company's Additives & Functional Products segment offers specialty coalescent, specialty and commodity solvents, paint additives, and specialty polymers; hydrocarbon and rosin resins; insoluble sulfur and anti-degradant rubber additives; performance resins; amine derivative-based building blocks; heat transfer and aviation fluids; organic acid-based solutions; and metam-based soil fumigants, thiram and ziram based fungicides, and plant growth regulators.

Featured Article: Understanding Market Liquidity

Get a free copy of the Zacks research report on Eastman Chemical (EMN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.